Jefferies is out with its report today on Health Mgt. Assoc. HMA, maintaining Buy.
In a note to clients, Jefferies writes, "Despite posting a $0.01 Q1 earnings beat, HMA's stock will likely be under pressure today given the degree of volume weakness the company experienced during the quarter. We would use this weakness as an opportunity to accumulate shares, believing that ongoing margin improvement and contribution from new acquisitions will yield good earnings results, particularly when volumes recover."
Jefferies maintains a $13 PT on HMA.
Shares of HMA closed Monday at $10.39, up 0.78% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in